Jerry Almonte De Leon, founder of OneNess Blockchain AI, proudly introduces Open Quantum, a platform dedicated to advancing Quantum-AI and Quantum-Cryptography. Open Quantum's breakthrough ...

Enjovo, a forward-thinking U.S.-based candy startup, is set to shake up the global confectionery industry with its unique approach to candy dispensing. The company has developed a patented ...

A vaccine study participant developed a serious nerve disorder Company and FDA investigating the single adverse event report Novavax Inc. shares fell 19% after US regulators placed a hold on the ...

Novavax shares drop as much as 24%, the most intraday since July, after the company said the US FDA has placed a clinical hold on its application for a Covid-flu combination and stand-alone flu ...

Nov 5 (Reuters) - Novavax (NVAX.O), opens new tab said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency (UKHSA) related to its COVID-19 ...

In early pandemic days, Novavax (NASDAQ: NVAX) shares soared as investors bet on the company's ability to bring a coronavirus vaccine to market. But as the biotech fell behind in the race and ...

Novavax ( (NVAX)) has issued an announcement. Novavax, Inc. and the UK Health Security Agency have reached a settlement to terminate their SARS-COV-2 Vaccine Supply Agreement, resolving disputes ...

Shares in Novavax fell by as much as one-fifth Wednesday morning after the company disclosed the Food and Drug Administration halted clinical testing of its combination vaccine for COVID-19 and ...

Graeme Sloan / Bloomberg via Getty Images The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu shot because of safety concerns.

Oct 16 (Reuters) - The U.S. Food and Drug Administration has put on hold a trial of Novavax's (NVAX.O), opens new tab COVID-influenza and its standalone flu vaccines after a participant who took ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put two of the biopharma's programs on hold in response to a case of nerve disease from a former ...